Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2010) 22 P61

ECE2010 Poster Presentations Adrenal (66 abstracts)

Comparison of plasma aldosterone/signal activity and aldosterone/active signal ratios in different clinical conditions

Zoltan Locsei 1 , Erzsebet Toldy 2, , Dora Horvath 1 , Rita Nagy 1 , Karoly Racz 3 , Istvan Szabolcs 6 & Gabor L Kovacs 4,

1First Department of Internal Medicine, Markusovszky Teaching Hospital of County Vas, Szombathely, Hungary; 2Central Laboratory of Markusovszky Teaching Hospital and Institute of Diagnostics and Man, Szombathely, Hungary; 3Second Institute of Internal Medicine, Semmelweis University, Budapest, Hungary; 4Institute of Laboratory Medicine, University of Pecs, Pecs, Hungary; 5Institute of Diagnostics and Management, University of Pecs, Pecs, Hungary; 6Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.

Because measurement of plasma signal activity (PRA) is time-consuming an automated method directly measuring active signal (REN) may be more suitable for clinical practice. The aim of the study was to analyse the diagnostic utility of REN and aldosterone (ALD)/REN ratio as compared to PRA and ALD/PRA ratio.

Materials and methods: PRA, REN (DiaSorin) and ALD (Immunotech) were simultaneously measured in 123 plasma samples (83 females and 40 males; mean age, 42±16 years) including samples from 38 healthy volunteers with normal blood pressure and without medication (controls), 25 healthy females taking oral contraceptives and 60 patients with verified hypertension (22 treated and 38 untreated). In the latter group 15 patients have adrenal adenomas.

Results: In the whole group of samples there was a weak but significant correlation (r=0.59; P<0.001) between PRA (1.24±1.26 ng/ml per h) and REN (28.7±44.4 μU/ml). In the lower concentration (PRA: 0.45±0.25 ng/ml per h; REN: 9.4±10.1 μU/ml) the correlation was weaker (r=0.38; P<0.001). PRA was undetectable in 11%, while REN in 4% of the samples. The ALD/REN ratio, but not the ALD/PRA ratio, was significantly (P<0.05) higher in women taking oral contraceptives than in those who did not (ALD/REN ratio, (40.6±37.9 vs 22.5±21.9 pmol/l per μU per ml). In hypertensive patients treated with β blockers the ALD/REN ratio was significantly higher (P<0.001, 119±111 pmol/l per μU per ml) than in controls, and in hypertensive patients taking medications other that β blockers (23±16 and 25±26 pmol/l per μU per ml, respectively). In patients with adrenal adenoma the ALD/PRA ratio, but not the ALD/REN ratio, was significantly higher than in controls (ALD/PRA ratio 41±104 vs 11±23 ng/dl per ng per ml per h).

Conclusions: There is a poor analytical correlation between the two methods, especially in the lower range of PRA/REN concentrations. The widely used screening method (ALD/PRA) should be replaced by the ALD/REN ratio only after careful interpretation of the different clinical conditions.

Article tools

My recent searches

No recent searches.